• Prostate cancers in black men could be missed through active surveillance
    Prostate cancers in black men could be missed through active surveillance

News & Views

Prostate cancers in black men could be missed through active surveillance

Prostate cancers in black men could be missed as a result of active surveillance, a new study has found.

The research from Johns Hopkins found that African-Americans diagnosed with low-risk prostate cancers are more likely than white men to have an aggressive disease that is unrecognised with existing diagnostic approaches.

A report of the study has been posted online in the Journal of Clinical Oncology, where it has been described as the biggest assessment of race-based health disparities in men diagnosed with a slow-growing, non-aggressive form of prostate cancer.

The findings highlighted that preoperative characteristics were similar for very-low-risk whites and blacks, but black men had worse Charlson comorbidity index scores, which assesses life expectancy.

A detailed analysis also showed that black men had a lower rate of organ-confined cancers at 87.9 per cent and a significantly higher hazard of prostate-specific antigen (PSA)-defined biochemical recurrence (BCR) of prostate cancer.

Urologist Edward M. Schaeffer, a co-author of the study, said: “This is critical information because if African-American men do have more aggressive cancers, as statistics would suggest, then simply monitoring even small cancers that are very low risk would not be a good idea because aggressive cancers are less likely to be cured.

“We think we are following a small, non-aggressive cancer, but in reality, this study highlights that in black men, these tumors are sometimes more aggressive than previously thought.”

He went on to say that alternate race-specific surveillance entry criteria should be developed and utilised for African-American men to guarantee oncologic parity with their white counterparts.

New strategies are also being developed to accurately risk-classify African-Americans with newly diagnosed prostate cancer, which should improve chances of survival.

However, Mr Schaeffer admitted that the figures are restricted because they are from a retrospective analysis of the experiences of a single academic medical centre.

Posted by Fiona Griffiths


Digital Edition

Lab Asia 31.6 Dec 2024

December 2024

Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...

View all digital editions

Events

Smart Factory Expo 2025

Jan 22 2025 Tokyo, Japan

Instrumentation Live

Jan 22 2025 Birmingham, UK

SLAS 2025

Jan 25 2025 San Diego, CA, USA

Arab Health

Jan 27 2025 Dubai, UAE

Nano Tech 2025

Jan 29 2025 Tokyo, Japan

View all events